首页> 外文期刊>Gut and Liver >Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
【24h】

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives

机译:间充质干细胞治疗肝病:现在和观点

获取原文
           

摘要

Mesenchymal stem cell transplantation is an emerging therapy for treating chronic liver diseases. The potential of this treatment has been evaluated in preclinical and clinical studies. Although the mechanisms of mesenchymal stem cell transplantation are still not completely understood, accumulating evidence has revealed that their immunomodulation, differentiation, and antifibrotic properties play a crucial role in liver regeneration. The safety and therapeutic effects of mesenchymal stem cells in patients with chronic liver disease have been observed in many clinical studies. However, only modest improvements have been seen, partly because of the limited feasibility of transplanted cells at present. Here, we discuss several strategies targeted at improving viable cell engraftment and the potential challenges in the use of extracellular vesicle-based therapies for liver disease in the future.
机译:间充质干细胞移植是一种治疗慢性肝病的新出现治疗。这种治疗的潜力已经在临床前和临床研究中进行了评估。虽然间充质干细胞移植机制仍未完全理解,但积累的证据表明,它们的免疫调节,分化和抗灰度性质在肝再生中发挥着至关重要的作用。在许多临床研究中观察到间充质干细胞在慢性肝病患者中的安全性和治疗效果。然而,只有适度的改进,部分原因是目前移植细胞的可行性有限。在这里,我们讨论了改善可行细胞植入的几种策略以及未来使用细胞外囊泡的疗法在使用细胞外囊泡疗法的潜在挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号